Towards end of presentation Ed says to the effect that WE see many opportunities in Europe between now and the U.S. launch.
Bring on the U.K. and Europe where we have all relevant approvals while we await FDA approval.
What a wonderful opportunity for a few U.S. and European m-health funds to dip their toes in the water and take a position in Isonea.
A two million dollar investment (5 million shares) per Fund is no big ask & will be forthcoming in the near future.
Towards end of presentation Ed says to the effect that WE see...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
